{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-228076","form_type":"8-K","ticker":"SYRE","cik":"0001636282","company_name":"Spyre Therapeutics, Inc.","filed_at":"2023-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.640541+00:00","generated_at":"2026-06-10T23:59:21.902091+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Aeglea appoints Scott Burrows as CFO, Heidy Abreu King-Jones as CLO; prior CFO transitions to advisory role","bullets":["Scott Burrows appointed CFO effective Sept 1, 2023, succeeding Jonathan Alspaugh; base salary $455K, target bonus 40%, sign-on $115K.","Heidy Abreu King-Jones appointed Chief Legal Officer & Corporate Secretary; both report to COO Cameron Turtle.","Jonathan Alspaugh transitions to strategic advisory role through Dec 31, 2023; he was President and CFO.","Burrows received inducement options for 10,121,441 shares and 3,373,814 RSUs; King-Jones options for 13,495,255 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-228076","json":"https://secwatch.observer/filing/0001193125-23-228076.json","markdown":"https://secwatch.observer/filing/0001193125-23-228076.md","text":"https://secwatch.observer/filing/0001193125-23-228076.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636282/000119312523228076/0001193125-23-228076-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636282/000119312523228076/d437285d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T23:59:21.902091+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f35f243e75","claim":"Scott Burrows was appointed as Chief Financial Officer at Spyre Therapeutics, Inc..","evidence_excerpt":"appointed Scott Burrows to succeed Jonathan Alspaugh as the Company’s Chief Financial Officer effective September 1, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1636282/000119312523228076/0001193125-23-228076-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}